Table of Contents
Specialty
NeurologyCommunity Submission Recommendations
DM1, DM2Featured in the Digital Academy
How Common is Myotonic Dystrophy in the United States? Findings from the Recent ...
Published: 24 avril 2020
This presentation will discuss the outcome of the recent study exploring the prevalence of myotonic dystrophy type 1 in the United Stat...
What Comes Next: Preparing for DM Clinical Trials - 2020 Virtual Conference
Published: 5 octobre 2020
With many potential drugs and treatments in development, this session explores the different stages of the clinical trials process
ARTHEx biotech - Meet the DM Drug Developers
Published: 19 juin 2021
Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments
Clinical Trial Readiness Workshop
Published: 28 septembre 2021
Originally presented on September 11th, 2021 as a part of the DM1 & DM2 Tracks at the 2021 Virtual MDF Annual Conference.
Clinical Updates: Cardiac Management, DM Clinical Research Network, and Brain Ma...
Published: 28 septembre 2021
Originally presented on September 11th, 2021 as a part of the Professionals Track at the 2021 Virtual MDF Annual Conference.
Research Dataset Presentations - 2022 MDF Annual Conference
Published: 4 novembre 2022
Suzanne McDermott, PhD, presents, Groups of Signs and Symptoms in adult-onset myotonic dystrophy type 1.
Avidity Biosciences Dec 2022 - Meet the DM Drug Developers
Published: 16 décembre 2022
Each month biotechnology, pharmaceutical and academic partners, large and small
Avidity Biosciences Topline Data - 2023 Meet the DM Drug Developers
Published: 24 mai 2023
Sarah Boyce, Avidity CEO, Dr. Steve Hughes, Avidity CMO
DM Drug Development & Approval Considerations with the FDA - 2023 MDF Annual...
Published: 21 novembre 2023
Gain insight and understanding on the important role the FDA plays in the drug approval process through a presentation from the FDA.
Pharma Day with Euro-DyMA - 2025 MDF Conference
Published: 16 juin 2025
The 5th Edition of Pharma Day was presented in partnership by Euro-DyMA (European Dystrophia Myotonica Association) and the Myotonic Dy...